Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The history now adds Revision: v3.6.3 and removes Revision: v3.6.2, updating the page's revision trail.
    Difference
    0.1%
    Check dated 2026-07-03T22:25:18.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The record history now shows a new Revision: v3.6.2 entry, replacing the previous Revision: v3.6.0 entry. This reflects an update to the versioning information in the study record and is a non-substantive UI/metadata change.
    Difference
    0.1%
    Check dated 2026-06-27T00:12:49.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study record now shows that recruitment is closed for participants, and the history adds a new revision label v3.6.0 while removing the previous v3.5.5 tag.
    Difference
    0.3%
    Check dated 2026-06-12T16:47:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The history includes a new revision tag v3.5.5, replacing v3.5.4, indicating an updated build of the page.
    Difference
    0.1%
    Check dated 2026-06-05T13:51:23.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a new page build. The change reflects release metadata rather than content updates to the study record.
    Difference
    0.1%
    Check dated 2026-05-15T05:49:57.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The record history page shows a new revision label (v3.5.3) replacing the previous v3.5.2, indicating a fresh release of the page's UI and metadata. This is a metadata update rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-04-30T18:44:08.000Z thumbnail image

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.